- Home
- PRPO vs TCBS Comparison
PRPO vs TCBS Comparison
Compare PRPO & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRPO | TCBS |
|---|---|---|
| Founded | N/A | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.4M | 48.6M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRPO | TCBS |
|---|---|---|
| Price | $24.04 | $16.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 18.6K | 2.2K |
| Earning Date | 05-12-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | 92.15 | ★ 327.27 |
| EPS | N/A | ★ 0.31 |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $54.52 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $9.67 | $15.10 |
| 52 Week High | $33.63 | $20.00 |
Technical Indicators
Market Signals| Indicator | PRPO | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 39.53 | 50.11 |
| Support Level | $22.96 | $16.79 |
| Resistance Level | $26.16 | $17.12 |
| Average True Range (ATR) | 1.84 | 0.17 |
| MACD | -0.15 | 0.03 |
| Stochastic Oscillator | 30.02 | 70.59 |
Price Performance
Historical ComparisonAbout PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.